Cardioprotective Effects Of Dexrazoxane Derivatives Against Chronic Anthracycline Cardiotoxicity Depend On Topoisomerase II Beta Inhibition And Prevention Of DNA Damage Signaling In The Heart-MedSci.cn

Cardioprotective Effects Of Dexrazoxane Derivatives Against Chronic Anthracycline Cardiotoxicity Depend On Topoisomerase II Beta Inhibition And Prevention Of DNA Damage Signaling In The Heart

Kollarova, P; Lencova, O; Karabanovich, G; Kubes, J; Vanova, N; Roh, J; Simunek, T; Sterbova, P; Sterba, M